Related Products
|
||||||
About
Apodex is a self-evolving heavy-duty solver for deep research, built to answer the questions that matter with verified reasoning rather than a quick chat reply. It reasons through hard problems step by step, checks every conclusion before moving to the next, and produces a verified brief with citations in every report. Designed for complex inquiries with no easy existing answer, Apodex performs deep research, explores evidence, and verifies each step so users can trust how the final conclusion was reached. Signed-in users can save every inquiry, return, and continue anytime, search across threads, branch off any report, and review a step-level reasoning trace. Apodex-1.0 is a verification-centric model for deep research that can run as a standard tool-using ReAct agent, while its heavy-duty mode deploys an asynchronous agent team where specialized sub-agents handle retrieval and verification, route findings through a shared evidence pool, and feed a global verifier.
|
About
FN2 is an autonomous stock decision engine. Instead of you running the same research loop every morning, FN2 dispatches AI agents that watch the markets, do the deep research on a schedule, and deliver the answer to your Inbox, Phone, or Discord.
Describe what you want to track in natural language: A ticker, a sector, a thesis, or a question like "alert me when NVDA's guidance changes" or pick a pre-built agent. FN2 turns it into an autonomous research agent that runs on your schedule: before the open, right after earnings, or weekly. Each agent reads earnings-call transcripts, pulls FRED macro data, screens tickers, builds charts, and reasons over all of it — then delivers a decision-ready brief, not a pile of raw data. No tabs, no screeners, no manual morning research. Built for serious individual investors and analysts who are drowning in tabs, transcripts, and screeners doing the same work by hand every day.
|
|||||
Platforms Supported
Windows
Not Supported
Mac
Not Supported
Linux
Not Supported
Cloud
Supported
On-Premises
Not Supported
iPhone
Not Supported
iPad
Not Supported
Android
Not Supported
Chromebook
Not Supported
|
Platforms Supported
Windows
Not Supported
Mac
Not Supported
Linux
Not Supported
Cloud
Supported
On-Premises
Not Supported
iPhone
Not Supported
iPad
Not Supported
Android
Not Supported
Chromebook
Not Supported
|
|||||
Audience
Researchers, analysts, and professionals requiring verified, cited briefs that reason through complex questions step by step
|
Audience
Individual investors, retail traders, financial analysts, RIAs, and finance professionals
|
|||||
Support
Phone Support
Not Supported
24/7 Live Support
Not Supported
Online
Supported
|
Support
Phone Support
Not Supported
24/7 Live Support
Not Supported
Online
Supported
|
|||||
API
Offers API
Not Supported
|
API
Offers API
Not Supported
|
|||||
Screenshots and Videos |
Screenshots and VideosNo images available
|
|||||
Pricing
No information available.
Free Version
Not Supported
Free Trial
Not Supported
|
Pricing
$30/month
Free Version
Supported
Free Trial
Not Supported
|
|||||
Reviews/
|
Reviews/
|
|||||
Training
Documentation
Supported
Webinars
Not Supported
Live Online
Not Supported
In Person
Not Supported
|
Training
Documentation
Supported
Webinars
Not Supported
Live Online
Not Supported
In Person
Not Supported
|
|||||
Company InformationApodex
Founded: 2025
United States
www.apodex.ai/
|
Company InformationFN2
Founded: 2026
United States
fn2.ai
|
|||||
Alternatives |
Alternatives |
|||||
|
|
||||||
|
|
||||||
|
|
||||||
Categories |
Categories |
|||||
Integrations
Apodex 1.1
Not Supported
|
||||||
|
|
|